8 Most Undervalued Biotech Stocks to Buy Right Now
On April 13, Tom Lee, Fundstrat's head of research, appeared on CNBC’s 'Power Lunch' to talk about his outlook on equities, what to expect in a wartime economy, and more.
Regeneron Pharmaceuticals Inc. (REGN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sivik Global Healthcare Krishen Sud | 4,000 | $3,091 | 2.35% | |
| 2. | Bayforest Capital Theodoros Tsagaris | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $487.01 | 2,557 | $1,245,286.62 | 23,880,537 | 2017-08-25 | Filing | |
| $485.99 | 2,681 | $1,302,949.65 | 23,877,980 | 2017-08-25 | Filing | |
| $485.28 | 5,723 | $2,777,256.30 | 23,875,299 | 2017-08-25 | Filing | |
| $484.21 | 2,000 | $968,420.00 | 23,869,576 | 2017-08-25 | Filing | |
| $482.87 | 4,485 | $2,165,687.20 | 23,867,576 | 2017-08-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $779.71 | 40 | $31,188.40 | 17,603 | 2026-04-01 | Filing | |
| $778.24 | 4 | $3,112.96 | 17,643 | 2026-04-01 | Filing | |
| $777.42 | 9 | $6,996.78 | 17,647 | 2026-04-01 | Filing | |
| $776.62 | 13 | $10,096.06 | 17,656 | 2026-04-01 | Filing | |
| $775.58 | 14 | $10,858.12 | 17,669 | 2026-04-01 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 72,430 | $54,240,724 | 0.54% | |
| 2. | 67,300 | $51,998,672 | 5.44% | |
| 3. | 45,270 | $34,977,413 | 1.82% | |
| 4. | 41,702 | $32,220,355 | 1.82% | |
| 5. | 39,712 | $30,683,080 | 0.57% |
News See All
Jim Cramer Weighed In on the Tech Market Divide and 11 Stocks to Watch Now
In this article, we will look at the stocks Jim Cramer discussed alongside the tech market divide.
Jim Cramer's Hottest GLP-1 and Weight Loss Stock Picks
In an appearance on CNBC's Fast Money in January, Ray Stevens, CEO of Structure Therapeutics, discussed the unmet potential in the obesity market.
8 Best Debt Free Stocks to Buy Right Now
The market environment has become more complicated following the recent energy shock tied to the Iran conflict, with inflation concerns resurfacing just as expectations for rate cuts were starting to ...
Is Regeneron Pharmaceuticals, Inc. (REGN) A Good Stock To Buy?
Is REGN a good stock to buy? We came across a bullish thesis on Regeneron Pharmaceuticals, Inc. on Ocular Capital’s Substack. In this article, we will summarize the bulls’ thesis on REGN.
Jim Cramer Looked at These 11 Stocks Recently
This very morning, Larry sent me an email saying, hey, you know what? It's time for Bitcoin to blast off.
Why Regeneron Pharmaceuticals (REGN) is One of the Top Gene Therapy Stocks to Buy According to Hedge Funds
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the top gene therapy stocks to buy according to hedge funds. Regeneron Pharmaceuticals, Inc.
Top 10 Gene Therapy Stocks to Buy According to Hedge Funds
On February 23, Lauren Goodwin, New York Life Investments, appeared on CNBC’s ‘Closing Bell’ to talk about the state of equity markets and tariff uncertainties.
FDA Accepts Regeneron (REGN) BLA for Garetosmab Under Priority Review
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is one of the best value stocks to buy now.
11 Best Value Stocks to Buy Now
On February 7, Richard Bernstein, the CEO of Richard Bernstein Advisors, joined 'The Exchange' on CNBC to discuss the current state of the equity markets and his firm's macro-driven investment strategy...